Stefan Berg
32Patents
6h-index
46Co-inventors
65Inventor score
Filing activity: Mar 22, 1996 → Aug 18, 2008
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6838061B1 | Reactor for carrying out gas-liquid, liquid, liquid-liquid or gas-liquid-solid chemical reactions | Performing Operations; Transporting | 20 | Expired |
| US6387899B1 | Substituted chroman derivatives | Human Necessities | 10 | Expired |
| US7595319B2 | Compounds having selective inhibiting effect at GSK3 | Chemistry; Metallurgy | 9 | Expired |
| US6479497B1 | Substituted chroman derivatives | Chemistry; Metallurgy | 8 | Expired |
| US7205314B2 | Compounds for the treatment of dementia related diseases | Chemistry; Metallurgy | 7 | Expired |
| US7399780B2 | 3-Heterocyclyl-indole inhibitors of glycogen synthase kinase-3 | Chemistry; Metallurgy | 6 | Expired |
| US7342022B2 | Compounds in the treatment of dementia related diseases, Alzheimer's Disease and conditions associated with glycogen synthase kinase-3 | Chemistry; Metallurgy | 6 | Expired |
| US6124283A | Substituted 1,2,3,4-tetrahydronaphthalene derivatives | Chemistry; Metallurgy | 5 | Expired |
| US6159971A | Combination of a 5-HT reuptake inhibitor and a H5-HT1B anatagonist or partial agonist | Human Necessities | 5 | Expired |
| US7078410B2 | 2-arylamino-pyrimidines for the treatment of GSK3-related disorders | Human Necessities | 5 | Expired |
| US6159972A | Combination of a selective 5-HT.sub.1A antagonist and a selective ub . h5-HT.s1B antagonist or partial agonist | Human Necessities | 3 | Expired |
| US8492584B2 | Process and apparatus for oxidizing organic compounds | Emerging Cross-Sectional Technologies | 3 | Active |
| US6384225B1 | Intermediates in the preparation of substituted chroman derivatives | Human Necessities | 3 | Expired |
| US7855213B2 | Compounds | Chemistry; Metallurgy | 3 | Active |
| US5726321A | Process for carrying out gas/liquid reactions under avoidance of a continuous gas phase | Emerging Cross-Sectional Technologies | 3 | Expired |
| US6159970A | Combination of a monoamine oxidase inhibitor and a h5-HT.sub.1B antagonist or partial agonist | Human Necessities | 2 | Expired |
| US7585853B2 | Compounds having selective inhibiting effect at GSK3 | Human Necessities | 2 | Expired |
| US7595321B2 | Compounds having selective inhibiting effect at GSK3 | Chemistry; Metallurgy | 2 | Expired |
| US7056939B2 | 4-(4Methoxybenzyl)-n′-(5-nitro1,3-thiazol-2-yl)urea and its use in the treatment of conditions associated with glycogen-synthase kinase-3 (gsk3) | Human Necessities | 1 | Expired |
| US6291458A | Morpholinobenzamide salts | Human Necessities | 1 | Expired |
| US6313118A | Substituted 1,2,3,4-tetrahydronaphthalene derivatives | Chemistry; Metallurgy | 1 | Expired |
| US7056921B2 | Substituted chroman derivatives | Chemistry; Metallurgy | 1 | Expired |
| US6548498B1 | Substituted indan derivatives | Chemistry; Metallurgy | 0 | Expired |
| US6410532B1 | Substituted 1,2,3,4-tetrahydronaphthalene derivatives | Chemistry; Metallurgy | 0 | Expired |
| US7439356B2 | Substituted indan derivatives | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.